BOT 3.85% 37.5¢ botanix pharmaceuticals ltd

That subjectivity is the biggest cause for concern, there's...

  1. 156 Posts.
    lightbulb Created with Sketch. 63
    That subjectivity is the biggest cause for concern, there's nothing to stop the FDA at the next review saying "close, but not quite. See you again in 6 months". There must or should be a mechanism for interim reviews or appeal if you're rejecting based on opinions rather than hard data.

    "Power corrupts; absolute power corrupts absolutely"
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
37.5¢
Change
-0.015(3.85%)
Mkt cap ! $680.2M
Open High Low Value Volume
39.0¢ 39.5¢ 37.5¢ $2.994M 7.824M

Buyers (Bids)

No. Vol. Price($)
15 1187260 37.5¢
 

Sellers (Offers)

Price($) Vol. No.
38.0¢ 94571 6
View Market Depth
Last trade - 16.10pm 20/09/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.